TRENDING
SPONSORED

Digilancer Freelancer Marketplace is launching in 2026

Join Waitlist →

Startups

Venture capital funding, new product launches, startup ecosystems, and business metrics.

Novus Health 2 raises $15M Series A funding round for its Solid-State EV Battery Chemistries

Introduction Based in Tech Hub, Novus Health 2 has officially announced that it raises $15M Series A funding round. The announcement represents a pivotal shift towards addressing critical bottlenecks in Solid-State EV Battery Chemistries across enterprise and commercial markets. Scaling Core Technology The funding round or product release aligns with the startup's long-term deployment goals. With a focus on optimizing execution paths, Novus Health 2 has built robust infrastructure components designed to support multi-tenant configurations. Founder and CEO Liam O'Connor elaborated on the vision during the press briefing: > "This partnership marks a significant milestone in our journey to democratize advanced workflows globally. We are positioning our technology stack as the primary integration engine for future enterprise architectures." Key Operational Highlights The startup reports strong performance metrics heading into this operational cycle: - Primary Investor: Bessemer Venture Partners - Core Focus Area: Solid-State EV Battery Chemistries - Latest Capital Infusion: $15M - Target Milestone Valuation: $90M - Quarter-over-Quarter Active Growth: +140% enterprise adoption rates Future Growth Horizons Moving forward, the company plans to utilize its current momentum to expand technical development pipelines and open satellite offices globally. In addition to scaling core software capabilities, Novus Health 2 will introduce dedicated developer sandbox channels by Q4, offering enhanced tooling for collaborative workflows.

Novus Health 2 raises $15M Series A funding round for its Solid-State EV Battery Chemistries
2 weeks ago Axios Pro
OrbitX 2 exits stealth mode with $4.5M Seed funding for its Custom ASIC Machine Learning Hardware

OrbitX 2 exits stealth mode with $4.5M Seed funding for its Custom ASIC Machine Learning Hardware

Introduction Based in Tech Hub, OrbitX 2 has officially announced that it exits stealth mode with $4.5M Seed funding. The announce...

2 weeks ago Inc. Magazine

NeuralCore 2 exits stealth mode with $4.5M Seed funding for its Neomorphic Brain-Chip Interfaces

Introduction Based in Tech Hub, NeuralCore 2 has officially announced that it exits s...

2 weeks ago EU-Startups

SaaSify Platforms 2 raises $15M Series A funding round for its Decentralized Micro-Transactions

Introduction Based in Tech Hub, SaaSify Platforms 2 has officially announced that it...

2 weeks ago Sifted EU

BioSphere Genomics 2 announces strategic enterprise partnership with Microsoft for its Nuclear Fusion Power Grids

Introduction Based in Tech Hub, BioSphere Genomics 2 has officially announced that it announces strategic enterprise partnership with Microsoft. The announcement represents a pivotal shift towards addressing critical bottlenecks in Nuclear Fusion Power Grids across enterprise and commercial markets. Scaling Core Technology The funding round or product release aligns with the startup's long-term deployment goals. With a focus on optimizing execution paths, BioSphere Genomics 2 has built robust infrastructure components designed to support multi-tenant configurations. Founder and CEO Michael Chen elaborated on the vision during the press briefing: > "Enterprise demand has surpassed our initial projections, and scaling our infrastructure is our top priority. We are positioning our technology stack as the primary integration engine for future enterprise architectures." Key Operational Highlights The startup reports strong performance metrics heading into this operational cycle: - Primary Investor: Kleiner Perkins - Core Focus Area: Nuclear Fusion Power Grids - Latest Capital Infusion: $5M - Target Milestone Valuation: $30M - Quarter-over-Quarter Active Growth: +140% enterprise adoption rates Future Growth Horizons Moving forward, the company plans to utilize its current momentum to expand technical development pipelines and open satellite offices globally. In addition to scaling core software capabilities, BioSphere Genomics 2 will introduce dedicated developer sandbox channels by Q4, offering enhanced tooling for collaborative workflows.

BioSphere Genomics 2 announces strategic enterprise partnership with Microsoft for its Nuclear Fusion Power Grids
2 weeks ago VentureBeat
QuantumX Labs 2 secures $60M Series B expansion round for its Digital Twin Urban Simulation

QuantumX Labs 2 secures $60M Series B expansion round for its Digital Twin Urban Simulation

Introduction Based in Tech Hub, QuantumX Labs 2 has officially announced that it secures $60M Series B expansion round. The announ...

2 weeks ago TechCrunch

CoreSaaS 2 announces strategic enterprise partnership with Microsoft for its Zero-Trust Cybersecurity Frameworks

Introduction Based in Tech Hub, CoreSaaS 2 has officially announced that it announces...

3 weeks ago Inc. Magazine

SentinelSec 2 secures $60M Series B expansion round for its Autonomous Drone Logistics

Introduction Based in Tech Hub, SentinelSec 2 has officially announced that it secure...

3 weeks ago Axios Pro

DataLoop AI 2 launches its enterprise developer beta for its Neomorphic Brain-Chip Interfaces

Introduction Based in Tech Hub, DataLoop AI 2 has officially announced that it launches its enterprise developer beta. The announcement represents a pivotal shift towards addressing critical bottlenecks in Neomorphic Brain-Chip Interfaces across enterprise and commercial markets. Scaling Core Technology The funding round or product release aligns with the startup's long-term deployment goals. With a focus on optimizing execution paths, DataLoop AI 2 has built robust infrastructure components designed to support multi-tenant configurations. Founder and CEO Sophia Martinez elaborated on the vision during the press briefing: > "Our breakthrough in solid-state efficiency unlocks completely new paradigms for developer experiences. We are positioning our technology stack as the primary integration engine for future enterprise architectures." Key Operational Highlights The startup reports strong performance metrics heading into this operational cycle: - Primary Investor: General Catalyst - Core Focus Area: Neomorphic Brain-Chip Interfaces - Latest Capital Infusion: $5M - Target Milestone Valuation: $30M - Quarter-over-Quarter Active Growth: +140% enterprise adoption rates Future Growth Horizons Moving forward, the company plans to utilize its current momentum to expand technical development pipelines and open satellite offices globally. In addition to scaling core software capabilities, DataLoop AI 2 will introduce dedicated developer sandbox channels by Q4, offering enhanced tooling for collaborative workflows.

DataLoop AI 2 launches its enterprise developer beta for its Neomorphic Brain-Chip Interfaces
3 weeks ago EU-Startups
Apex Robotics 2 pivots to fully generative API-first architecture for its Decentralized Micro-Transactions

Apex Robotics 2 pivots to fully generative API-first architecture for its Decentralized Micro-Transactions

Introduction Based in Tech Hub, Apex Robotics 2 has officially announced that it pivots to fully generative API-first architecture...

3 weeks ago Sifted EU

Stellar Computing 2 launches its enterprise developer beta for its CRISPR Gene Synthesis Platforms

Introduction Based in Tech Hub, Stellar Computing 2 has officially announced that it...

4 weeks ago VentureBeat

VeloCity Logistics 2 pivots to fully generative API-first architecture for its Generative AI Video Pipelines

Introduction Based in Tech Hub, VeloCity Logistics 2 has officially announced that it...

4 weeks ago TechCrunch